نتایج جستجو برای: biologic markers

تعداد نتایج: 278893  

Journal: :The Journal of the American Academy of Orthopaedic Surgeons 2009
Benjamin W Sears Michael D Stover John Callaci

The natural inflammatory response to major trauma may be associated with the development of a systemic inflammatory state, remote multiorgan failure, and death. Although a controlled inflammatory response is beneficial, an exaggerated response can cause serious adverse systemic effects. Early identification of high-risk patients, based on inflammatory markers and genomic predisposition, should ...

Journal: :The oncologist 2010
Cathy Eng

Targeted biologic agents have an established role in treating metastatic colorectal cancer (mCRC). Bevacizumab, a recombinant monoclonal antibody against the vascular endothelial growth factor ligand is approved by the U.S. Food and Drug Administration (FDA) for bevacizumab-naïve patients. Cetuximab, a chimeric monoclonal antibody (mAb) against the epidermal growth factor receptor (EGFR) is FDA...

Journal: :Frontiers in Immunology 2023

Spondyloarthritis is a group of immune-mediated rheumatic disorders that significantly impact patients’ physical function and quality life. Patients with spondyloarthritis experience greater prevalence cardiometabolic disorders, such as obesity, hypertension, dyslipidemia diabetes mellitus, these comorbidities are associated increased disease activity risk cardiovascular events. This narrative ...

2008
Izidore S. Lossos

Diffuse large B-cell lymphoma (DLBCL) it the most common adult Non-Hodgkin’s lymphoma with an annual incidence of more than 25,000 cases in the United States. Although DLBCL has characteristic morphology, marked immunophenotypic, cytogenetic and molecular heterogeneity underlies the variable clinical outcome of DLBCL patients. Consequently, it is expected that clinical surrogates, such as the i...

Journal: :Blood 2002
Jean Feuillard Marie-Christine Jacob Françoise Valensi Marc Maynadié Rémy Gressin Laurence Chaperot Christine Arnoulet Françoise Brignole-Baudouin Bernard Drénou Eliane Duchayne Annie Falkenrodt Richard Garand Emanuelle Homolle Bernard Husson Emilienne Kuhlein Geneviève Le Calvez Danielle Sainty Marie-France Sotto Franck Trimoreau Marie-Christine Béné

CD4(+)CD56(+) malignancies are rare hematologic neoplasms, which were recently shown to correspond to the so-called type 2 dendritic cell (DC2) or plasmacytoid dendritic cells. This study presents the biologic and clinical features of a series of 23 such cases, selected on the minimal immunophenotypic criteria defining the DC2 leukemic counterpart, that is, coexpression of CD4 and CD56 in the a...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Yoko Takahashi Michael E Kupferman Diana Bell Tilahun Jiffar June Goo Lee Tong-Xin Xie Ning-Wei Li Mei Zhao Mitchell J Frederick Alexander Gelbard Jeffrey N Myers Ehab Y Hanna

PURPOSE Sinonasal undifferentiated carcinoma (SNUC) is a rare and aggressive cancer. Despite the use of multimodality treatment, the overall prognosis remains poor. To better understand the biologic features of SNUC and help develop new therapies for the disease, we established SNUC cell lines and characterized their biologic behaviors. EXPERIMENTAL DESIGN Cell lines were established from a p...

2015
Joseph Pidala Gregory C. Bloom Steven Eschrich Minnie Sarwal Steve Enkemann Brian C. Betts Francisca Beato Sean Yoder Claudio Anasetti

Biologic markers of immune tolerance may facilitate tailoring of immune suppression duration after allogeneic hematopoietic cell transplantation (HCT). In a cross-sectional study, peripheral blood samples were obtained from tolerant (n = 15, median 38.5 months post-HCT) and non-tolerant (n = 17, median 39.5 post-HCT) HCT recipients and healthy control subjects (n = 10) for analysis of immune ce...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014
Judith S Kaur Robert A Vierkant Timothy Hobday Daniel Visscher

BACKGROUND Breast cancer is not a homogeneous disease, but several different and unique subtypes defined by gene expression analysis. Incidence and mortality rates vary by almost 3-fold between Alaska (highest) and the Southwestern tribes (lowest). We hypothesized that these differences may be due to, in part, varying levels of biologic tumor aggressiveness. METHODS A biorepository of the Nor...

Journal: :Environmental Health Perspectives 1995
K Hooper G C Clark

Studies of perinatal exposures to dioxin-like compounds (DLCs), coplanar polycyclic halogenated aromatics whose prototype is 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), have employed a variety of outcome measures to investigate effects on the reproductive/developmental, endocrine, immune, and neurobehavioral systems. The effects include infertility, growth retardation, fetal loss, changed sexua...

Journal: :Oncology nursing forum 2014
Paul D Loprinzi Hyo Lee

PURPOSE/OBJECTIVES To review the extant literature on the link between physical activity and health outcomes among cancer survivors; identify evidence-based strategies to promote physical activity among this population; and conduct an epidemiologic study based on gaps from the literature review, examining the association between physical activity and various biologic markers. DATA SOURCES The...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید